The purpose of this study is to examine the dose-response relationship of esketamine in combination with propofol for children with Autism Spectrum Disorder undering colonoscopy.
Autistic children appear with significant frequency for medical services, lots of which requiring procedural sedation or anaesthesia. They have often been described as difficult to sedate or anesthetize due to a variety of ASD symptoms. It is a challenging task to provide safe and effective sedation during the colonoscopic procedure in autism children. Propofol sedation for endoscopic procedures is safe and acceptable for children, especially those who express significant anxiety. Propofol-based sedation turned out to be the most effective dosage regimens, with effectiveness comparable to general anesthesia. The addition of certain dose ketamine to propofol may increase the effectiveness without creating more adverse events.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
46
esketamine dose will be 0.3 mg/kg. Propofol dose for the first patient will be 2.5 mg/kg. Doses for the subsequent patients will increase or decrease by 0.8 mg/kg using the Dixon Up and Down method.
esketamine dose will be 0.6 mg/kg. Propofol dose for the first patient will be 2.0 mg/kg. Doses for the subsequent patients will increase or decrease by 0.4 mg/kg using the Dixon Up and Down method.
propofol
Sir Run Run Hospital
Nanjing, Jiangsu, China
Dose of Propofol Required to Prevent Movement (Response) to Insertion of colonoscpopy 1
The objective is to determine the effective bolus dose in 50% of subjects (ED50) of propofol in combination with ketamine 0.3, 0.6mg/kg that produces an adequate depth of anesthesia to prevent minimal or no movement on colonoscopy insertion in children with Autism spectrum disorder.
Time frame: Procedure (This outcome is measured at the time of insertion of colonoscopy)
Dose of Propofol Required to Prevent Movement (Response) to Insertion of colonoscpopy 2
The objective is to determine the effective bolus dose in 95% of subjects (ED50) of propofol in combination with ketamine 0.3, 0.6mg/kg that produces an adequate depth of anesthesia to prevent minimal or no movement on colonoscopy insertion in children with Autism spectrum disorder.
Time frame: Procedure (This outcome is measured at the time of insertion of colonoscopy)
movement score during the procedure
(1 = no movement; 2 = semipurposeful allowing continuation of the procedure; 3 = vigorous purposeful movements withholding the procedure)
Time frame: during the procudure
arterial blood pressure
arterial blood pressure was measured noninvasively at four time points:T0: before induction of sedation,T1: immediately after induction of sedation, T2: complete evaluation of the coln through colonoscopy, T3: at the end of colonic TET procedure。
Time frame: during the procudure
adverse event
(including hypoxia (SpO2 \<93% for \>10 s) or respiratory depression (apnea \>15 s), hypotension (MAP \< 20% from baseline) or bradycardia (HR \< 60 x/min and/or decrease in HR \> 20% from baseline) were recorded.
Time frame: during the procedure - 24 hours after procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.